2024-03-29T05:42:51Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_686D1C598803
2024-03-23T02:28:53Z
serval:BIB_686D1C598803
PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy
10.1016/j.jtho.2016.09.093
27969525
Owonikoko
T.
author
Ready
N.
author
Postmus
P.
author
Reck
M.
author
Peters
S.
author
Pieters
A.
author
Selvaggi
G.
author
Fairchild
J.
author
Govindan
R.
author
inproceedings
abstract
2016-11
Elsevier BV
Journal of Thoracic Oncology
1556-0864
1556-0864
11
conference publication
11
S306-S307
ALK
NGS
NSCLC
RT-PCR
Oncology
Pulmonary and Respiratory Medicine
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish